Announced
Financials
Tags
Private Equity
Friendly
allergy treatments
Pharmaceuticals
Acquisition
Public
Pending
Single Bidder
United Kingdom
Cross Border
Majority
Mandatory Offer
Synopsis
ZQ Capital, an investment firm, offered to acquire Allergy Therapeutics, a specialty pharmaceutical company focused upon the diagnosis and treatment of allergy, for £48m.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.